Quantitative Evaluation of Antibiotics Use Trend in One Puskesmas in Bengkulu City: ATC/DDD and DU 90% Methods
DOI:
https://doi.org/10.30595/pharmacy.v0i0.14951Keywords:
Antibiotics, Anatomical Therapeutic Chemical, Defined Daily Dose, Drugs Utilization 90%, PuskesmasAbstract
Irrational use of antibiotics results in decreased effectiveness of antibiotics due to inappropriate use of therapeutic doses or methods of use. This causes the bacteria to become resistant to antibiotic therapy. Periodic evaluation of antibiotic use is necessary. This study aims to evaluate the use of antibiotics quantitatively in one of the Puskesmas in Bengkulu City in 2021. This type of research is descriptive research. The sample used is an antibiotic prescription in 2021 and is taken by total sampling. This research uses the Anatomical Therapeutic Chemical/Defined Daily Dose (ATC/DDD) and Drugs Utilization 90% (DU 90%) methods. The results obtained were the number of prescriptions containing antibiotics as many as 1422 prescriptions (18.40%) of the total prescriptions (7730 prescriptions). The antibiotic prescriptions consisted of 1205 prescriptions for oral preparations and 217 prescriptions for topical preparations. There are 9 types of antibiotics used during 2021, namely Amoxicillin, Ciprofloxacin, Cefixime, Chloramphenicol, Gentamicin, Oxytetracycline, Levofloxacin, Tetracycline, and Tiamphenicol. The most widely used antibiotic was Amoxicillin (92.28%) with a DDDs per 1000 inhabitants per day value of 429.27 followed by Ciprofloxacin (5.06%) with a DDD value of 30.47. So it can be concluded that the most use of antibiotics in 2021 in one of the Puskesmas in Bengkulu City is Amoxicillin.
References
Andriani, Y., Martua, A.S. and Andriani, M. (2021) ‘Evaluasi Penggunaan Antibiotik Dengan Metode Atc/Ddd Dan Du 90% Di Puskesmas Aur Duri Kota Jambi Periode 2016-2018’, Jurnal Ilmiah As-Syifaa, 12(2), pp. 91–98. doi:10.33096/jifa.v12i2.628.
Katzung, B.G., Masters, S.B. and Trevor, A.J. (2012) Basic and Clinical Pharmacology. 12th edn. United States: The McGraw-Hill Companies, Inc.
Kementerian Kesehatan RI (2021) Panduan Penatagunaan Antimikroba di Rumah Saki. 1st edn.
Klein, E.Y. et al. (2018) ‘Global increase and geographic convergence in antibiotic consumption between 2000 and 2015’, Proceedings of the National Academy of Sciences of the United States of America, 115(15), pp. E3463–E3470. doi:10.1073/pnas.1717295115.
Langford, B.J. et al. (2020) ‘Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis’, Clinical Microbiology and Infection, 26(12), pp. 1622–1629. doi:10.1016/j.cmi.2020.07.016.
Martínez-Casanova, J. et al. (2021) ‘Risk factors for amoxicillin-clavulanate resistance in community-onset urinary tract infections caused by escherichia coli or klebsiella pneumoniae: The role of prior exposure to fluoroquinolones’, Antibiotics, 10(5). doi:10.3390/antibiotics10050582.
Pemerintah Provinsi Bengkulu (2022) Perkembangan Kasus COVID 19 Provinsi Bengkulu. Available at: https://covid19.bengkuluprov.go.id/Databengkulu.
Pratiwi, R.H. (2017) ‘Mekanisme Pertahanan Bakteri Patogen terhadap Antibiotik’, Journal Pro-Life, 4(2), pp. 418–429.
Shallcross, L. et al. (2017) ‘Antibiotic prescribing frequency amongst patients in primary care: A cohort study using electronic health records’, Journal of Antimicrobial Chemotherapy, 72(6), pp. 1818–1824. doi:10.1093/jac/dkx048.
Sholih, M.G., Sudarjat, H. and Saula, L.S. (2019) ‘Gambaran Penggunaan Antibiotik Berdasarkan metode ATC / DDD dan DU 90 % di salah satu PUSKESMAS Karawang’, Health Science Growth, (Ddd), pp. 31–37. Available at: https://www.whocc.no/atc_ddd_index/.
Sitepu, R., Cahyono, T.T. and Monica, E. (2020) ‘Evaluasi Penggunaan Antibiotik Dengan Metode Atc/Ddd Dan Pdd Dengan Du 90% Pada Penderita Ispa Non Pneumonia Di Puskesmas Kabupaten Sampang’, Jurnal JKFT, 5(1), pp. 16–22. Available at: http://jurnal.umt.ac.id/index.php/jkft/article/view/2664.
Van Boeckel, T.P. et al. (2014) ‘Global antibiotic consumption 2000 to 2010: An analysis of national pharmaceutical sales data’, The Lancet Infectious Diseases, 14(8), pp. 742–750. doi:10.1016/S1473-3099(14)70780-7.
White, A.R. (2004) ‘Augmentin(R) (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent’, Journal of Antimicrobial Chemotherapy, 53(90001), pp. 3i – 20. doi:10.1093/jac/dkh050.
WHO Collaborating Centre for Drug Statistics Methodology (2022) Guidelines for ATC classification and DDD assignment 2022, World Health Organization.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
